scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Hong-Bing Shen | |
Guang-Fu Jin | |||
Han-Ze Zhang | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus | Q24250288 | ||
A Large-scale genetic association study of esophageal adenocarcinoma risk | Q24626024 | ||
Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study | Q24648727 | ||
Epidemiology and pathogenesis of esophageal cancer | Q28213313 | ||
Genomewide association studies and assessment of the risk of disease | Q28288414 | ||
Environmental causes of esophageal cancer | Q28388848 | ||
High-temperature beverages and foods and esophageal cancer risk--a systematic review | Q28391887 | ||
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study | Q28396223 | ||
Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations | Q28943370 | ||
Global patterns of cancer incidence and mortality rates and trends | Q34127168 | ||
Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1 | Q34132629 | ||
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma | Q34162606 | ||
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study | Q34363424 | ||
Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. | Q50661717 | ||
Role of GSTM3 polymorphism in the risk of developing esophageal cancer. | Q54562555 | ||
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. | Q55051385 | ||
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma | Q58204833 | ||
Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World | Q58484706 | ||
The Linxian trials: mortality rates by vitamin-mineral intervention group | Q71576318 | ||
Precursor lesions of oesophageal cancer in high-risk populations in Iran and China | Q72524440 | ||
An overview of cancer survival in developing countries | Q77294725 | ||
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer | Q79754864 | ||
Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma | Q80396549 | ||
Favorable genetic polymorphisms predictive of clinical outcome of chemoradiotherapy for stage II/III esophageal squamous cell carcinoma in Japanese | Q80434021 | ||
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
Association of GSTP1 polymorphism and survival for esophageal cancer | Q95820187 | ||
Clinical practice. Barrett's Esophagus | Q34563466 | ||
Cancer survival in five continents: a worldwide population-based study (CONCORD). | Q34798041 | ||
Epidemiologic trends in esophageal and gastric cancer in the United States | Q34993233 | ||
Pickled vegetables and the risk of oesophageal cancer: a meta-analysis | Q35009841 | ||
Natural selection in neoplastic progression of Barrett's esophagus | Q36206969 | ||
Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis | Q36479652 | ||
Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer | Q36612480 | ||
The prognostic significance of genetic polymorphisms (Methylenetetrahydrofolate Reductase C677T, Methionine Synthase A2756G, Thymidilate Synthase tandem repeat polymorphism) in multimodally treated oesophageal squamous cell carcinoma | Q36613626 | ||
Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology | Q36617994 | ||
Are squamous and adenocarcinomas of the esophagus the same disease? | Q36690742 | ||
Alcohol, tobacco, and diet in relation to esophageal cancer: the Shanghai Cohort Study | Q36692691 | ||
Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran | Q36696475 | ||
Genetic polymorphisms and esophageal cancer risk | Q36901056 | ||
Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005 | Q37330745 | ||
Genetic variations in esophageal cancer risk and prognosis | Q37425391 | ||
Cancer survival in Africa, Asia, and Central America: a population-based study | Q38432918 | ||
Continuing rapid increase in esophageal adenocarcinoma in England and Wales | Q39171596 | ||
Esophageal and gastric cardia cancers on 4238 Chinese patients residing in municipal and rural regions: a histopathological comparison during 24-year period | Q39850373 | ||
The changing incidence of oesophageal cancer | Q40720405 | ||
Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk | Q43288045 | ||
Family history of cancer and risk of esophageal and gastric cancers in the United States | Q43629522 | ||
Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China | Q43882248 | ||
Cancer mortality in Chinese immigrants to New York City. Comparison with Chinese in Tianjin and with United States-born whites | Q43882639 | ||
Rising incidence of clinically evident Barrett's oesophagus in The Netherlands: a nation-wide registry of pathology reports | Q44828036 | ||
Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation | Q46768034 | ||
Cancer incidence patterns in Koreans in the US and in Kangwha, South Korea | Q46910671 | ||
Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma. | Q47879656 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported | Q15643954 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adenocarcinoma | Q356033 |
esophageal cancer | Q372701 | ||
squamous cell carcinoma | Q681817 | ||
esophageal neoplasm | Q56014520 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 281-6 | |
P577 | publication date | 2012-06-01 | |
P1433 | published in | Chinese Journal of Cancer | Q15760211 |
P1476 | title | Epidemiologic differences in esophageal cancer between Asian and Western populations | |
P478 | volume | 31 |
Q39066150 | ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma |
Q93198681 | Analysis of Differentially Expressed Genes in a Chinese Cohort of Esophageal Squamous Cell Carcinoma |
Q96231197 | Apatinib suppresses tumor progression and enhances cisplatin sensitivity in esophageal cancer via the Akt/β-catenin pathway |
Q36266291 | Association Between p21 Ser31Arg Polymorphism and Gastrointestinal Tract Tumor Risk: A Meta-analysis |
Q37118354 | Association between alcohol dehydrogenase-2 gene polymorphism and esophageal cancer risk: a meta-analysis |
Q41143120 | Association of TP53 codon 72 genotype polymorphism and environmental factors with esophageal squamous cell carcinoma in the Mongolian population of the Chinese region of Inner Mongolia |
Q94950682 | Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study |
Q60045642 | Cellular and clinicopathological features of the IL-33/ST2 axis in human esophageal squamous cell carcinomas |
Q36218666 | Central Obesity and H. pylori Infection Influence Risk of Barrett's Esophagus in an Asian Population |
Q47140849 | Combination of histoculture drug response assay and qPCR as an effective method to screen biomarkers for personalized chemotherapy in esophageal cancer |
Q37103493 | Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma |
Q36341510 | Comparative proteome analysis of human esophageal cancer and adjacent normal tissues |
Q58803143 | Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus |
Q33589032 | Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma |
Q47271716 | Deficiency of IL-18 Aggravates Esophageal Carcinoma Through Inhibiting IFN-γ Production by CD8+T Cells and NK Cells |
Q37700216 | Demographic and lifestyle factors and survival among patients with esophageal and gastric cancer: The Biobank Japan Project |
Q93373353 | Determining Overall Survival and Risk Factors in Esophageal Cancer Using Censored Quantile Regression |
Q50200204 | Dietary Patterns and Risk of Esophageal Cancer Mortality: The Japan Collaborative Cohort Study |
Q37361998 | Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER database |
Q90798452 | Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis |
Q42267749 | Effect of SATB1 silencing on the proliferation, invasion and apoptosis of TE-1 esophageal cancer cells |
Q37406413 | Effect of a paclitaxel-eluting metallic stent on rabbit esophagus |
Q37349021 | Effectiveness evaluation of organized screening for esophageal cancer: a case-control study in Linzhou city, China. |
Q92713111 | Efficacy of irinotecan-based chemotherapy after exposure to an anti-PD-1 antibody in patients with advanced esophageal squamous cell carcinoma |
Q89635701 | Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling |
Q64324935 | Esophageal Adenocarcinoma: Opportunities for Targeted Prevention in Ohio |
Q28076178 | Esophageal Cancer in Golestan Province, Iran: A Review of Genetic Susceptibility and Environmental Risk Factors |
Q26799758 | Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries |
Q30571618 | Establishing a rabbit model of malignant esophagostenosis using the endoscopic implantation technique for studies on stent innovation |
Q49907705 | Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma |
Q58590446 | Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma |
Q64881347 | Factors Affecting Long-Survival of Patients with Esophageal Cancer Using Non-Mixture Cure Fraction Model |
Q47136146 | Factors associated with the high prevalence of oesophageal cancer in Western Kenya: a review |
Q38893221 | Global trends in esophageal cancer |
Q37560716 | Heavy alcohol intake is a risk factor for esophageal squamous cell carcinoma among middle-aged men: A case-control and simulation study |
Q37682634 | Helicobacter pylori infection--a boon or a bane: lessons from studies in a low-prevalence population |
Q28548040 | Identification of New Candidate Genes and Chemicals Related to Esophageal Cancer Using a Hybrid Interaction Network of Chemicals and Proteins |
Q90263373 | Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities |
Q35974653 | Incidence of esophageal cancer in Sri Lanka: Analysis of cancer registry data and comparison with other South Asian populations. |
Q87387712 | Increased MMP-21 expression in esophageal squamous cell carcinoma is associated with progression and prognosis |
Q52622936 | Intakes of citrus fruit and risk of esophageal cancer: A meta-analysis. |
Q42377399 | Integration of human papillomavirus 16 in esophageal carcinoma samples |
Q54937524 | Integration sites of human papillomavirus 18 in esophageal cancer samples. |
Q36533205 | Metastatic lymph node ratio, 6th or 7th AJCC edition: witch is the best lymph node classification for esophageal cancer? Prognosis factor analysis in 487 patients |
Q38997883 | Morbidity, Disability and Death Rates of The Population Due to Malignant Neoplasms in Uralsk City in The Republic of Kazakhstan |
Q39015045 | Outcomes of definitive chemoradiation in patients with esophageal cancer |
Q37613600 | PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail |
Q92756976 | PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma |
Q51552634 | PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma. |
Q39174794 | Patterns of care and survival outcomes in the treatment of esophageal melanoma |
Q64259309 | Possible biomarkers for predicting lymph node metastasis of esophageal squamous cell carcinoma: a review |
Q50114288 | Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis. |
Q54089309 | Prevalence of the integration status for human papillomavirus 16 in esophageal carcinoma samples. |
Q57817606 | Prognostic Value of Nicotinamide N-Methyltransferase Expression in Patients With Solid Tumors: A Systematic Review and Meta-Analysis |
Q37358138 | Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma |
Q64120596 | Prognostic impact of cigarette smoking on the survival of patients with established esophageal squamous cell carcinoma receiving radiotherapy: A retrospective study from southern China |
Q55056445 | Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis. |
Q47296527 | Prognostic role of initial pan-endoscopic tumor length at diagnosis in operable esophageal squamous cell carcinoma undergoing esophagectomy with or without neoadjuvant concurrent chemoradiotherapy |
Q49609504 | Prognostic value of lymph node count on survival in pathologically node-negative oesophageal squamous cell cancer |
Q39171528 | Screening and Preventive Strategies in Esophagogastric Cancer |
Q41303545 | Somatically Acquired LINE-1 Insertions in Normal Esophagus Undergo Clonal Expansion in Esophageal Squamous Cell Carcinoma |
Q52688051 | Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma. |
Q92189129 | Surgical principles for optimal treatment of esophagogastric junction adenocarcinoma |
Q90333943 | Targeted Therapies and Immunotherapies in the Treatment of Esophageal Cancers |
Q40248684 | The Global Burden of Esophageal Cancer: A Disability-Adjusted Life-Year Approach |
Q61799238 | The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer: a meta-analysis of clinical studies |
Q34517533 | The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma. |
Q41202595 | The extent of lymphadenectomy in esophageal resection for cancer should be standardized |
Q37520658 | The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China |
Q33714435 | Trends in esophageal and esophagogastric junction cancer research from 2007 to 2016: A bibliometric analysis |
Q92617459 | miR-143 inhibits migration and invasion through regulating LASP1 in human esophageal cancer |
Search more.